<DOC>
	<DOCNO>NCT01681186</DOCNO>
	<brief_summary>This study involve 2 part , Part A Part B . The purpose Part A evaluate safety side effect LY2940680 healthy people . Part A involve two group participant , take two single dos LY2940680 different dose level . There minimum 14 day washout period participant 's dos . The purpose Part B study much study drug , capsule tablet form , get bloodstream long body take get rid . In addition , effect food proton pump inhibitor LY2940680 study . Part B involve one group participant take four single dose 100 mg LY2940680 . There minimum 7 day washout period dos . Participants may enroll one part . Screening require within 28 day prior start study .</brief_summary>
	<brief_title>A Study LY2940680 Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Healthy sterile male surgically sterile female postmenopausal female , determine medical history physical examination Body mass index 18.5 32.0 kilogram per meter square ( kg/m^2 ) Have clinical laboratory test result within normal reference range Have give write informed consent approve Lilly ethical review board ( ERB ) govern site Prepared eat entire high fat breakfast Are currently enrol , complete discontinue within last 30 day , clinical trial involve investigational product Have know allergy LY2940680 , related compound component formulation , know allergy lansoprazole ( Part B ) Have previously complete withdrawn study study investigate LY2940680 , previously receive investigational product . Participants Part A allow participate Part B Have abnormality 12lead electrocardiogram ( ECG ) Have history current cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data ( cholecystectomy appendectomy allow surgery least 6 month prior screen ) Regularly use know drug abuse and/or show positive finding urinary drug screen Show evidence human immunodeficiency virus ( HIV ) infection and/or positive human HIV antibody Show evidence hepatitis C and/or positive hepatitis C antibody Show evidence hepatitis B and/or positive hepatitis B surface antigen Have use intend use overthecounter prescription medication within 14 day prior dose study . Exception : participant may continue hormone replacement therapy ( HRT ; estrogen ) Use herbal supplement , grapefruit juice , grapefruit , Seville orange juice , Seville oranges , Starfruit within 7 day prior dose study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>